These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2009147)

  • 61. Angiotensin converting enzyme inhibitors in perspective: an update.
    Burrell LM; Johnston CI
    Aust Fam Physician; 1993 Jul; 22(7):1243-7, 1251, 1255. PubMed ID: 8373316
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [ACE inhibitors in the diagnosis and therapy of various forms of hypertension].
    Greminger P; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1988 Apr; 118(14):495-501. PubMed ID: 2897714
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus.
    Mugellini A; Preti P; Zoppi A; Corradi L; Fogari E; Derosa G; Fogari R
    J Hum Hypertens; 2004 Oct; 18(10):687-91. PubMed ID: 15071488
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy and safety of imidapril in patients with essential hypertension: a double-blind comparison with captopril.
    Huang PJ; Chien KL; Chen MF; Lai LP; Chiang FT
    Cardiology; 2001; 95(3):146-50. PubMed ID: 11474160
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Does the combination of ACE inhibitor and calcium antagonist control hypertension and improve quality of life? The LOMIR-MCT-IL study experience.
    Amir M; Cristal N; Bar-On D; Loidl A
    Blood Press Suppl; 1994; 1():40-2. PubMed ID: 8205297
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Manidipine plus delapril in patients with Type 2 diabetes and hypertension: reducing cardiovascular risk and end-organ damage.
    Coca A
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):147-59. PubMed ID: 17338661
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Usefulness of angiotensin converting enzyme inhibitors in the diagnosis of renovascular hypertension. II. Comparison of the effect of angiotensin converting enzyme inhibition on reno-scintigraphic curves with DTPA in patients with essential and renovascular hypertension].
    Posadzy-Małaczyńska A
    Przegl Lek; 1997; 54(7-8):524-8. PubMed ID: 9480462
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Newer ACE inhibitors. A look at the future.
    Salvetti A
    Drugs; 1990 Dec; 40(6):800-28. PubMed ID: 2078997
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Effectiveness and tolerance of benazepril versus captopril in patients with hypertension].
    Ol'binskaia LI; Golubev SA; Morozova TE
    Klin Med (Mosk); 1995; 73(5):36-8. PubMed ID: 8815273
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacokinetics of a new angiotensin I converting enzyme inhibitor (delapril) in patients with deteriorated kidney function and in normal control subjects.
    Onoyama K; Nanishi F; Okuda S; Oh Y; Fujishima M; Tateno M; Omae T
    Clin Pharmacol Ther; 1988 Mar; 43(3):242-9. PubMed ID: 3345615
    [TBL] [Abstract][Full Text] [Related]  

  • 71. ACE inhibitors. Differential use in elderly patients with hypertension.
    Israili ZH; Hall WD
    Drugs Aging; 1995 Nov; 7(5):355-71. PubMed ID: 8573991
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drug therapy of renovascular hypertension.
    Rosenthal T
    Drugs; 1993 Jun; 45(6):895-909. PubMed ID: 7691497
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Benefits of delapril in hypertensive patients along the cardiovascular continuum.
    González-Juanatey JR; Cordero A
    Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):271-81. PubMed ID: 23469905
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical evaluation of delapril in Japan. Report from the Japan Study Group on Delapril.
    Ogihara T; Kaneko Y; Ikeda M; Yamada K; Omae T; Arakawa K; Ishii M; Yoshinaga K; Kumahara Y; Kokubu T
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):42S-45S. PubMed ID: 2009147
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Blood pressure and metabolic response to converting enzyme inhibitor in hypertensive patients: comparison between delapril and captopril].
    Chu TS; Wu MS; Chen YM; Wu KD
    J Formos Med Assoc; 1992 Dec; 91 Suppl 4():S288-92. PubMed ID: 1363526
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.